Combining artificial intelligence and genetics has allowed researchers to study the part of the eye that gives us sharp central vision in amazing detail for the first time. Subscribe to our newsletter ...

Drug development for neurodegenerative diseases is struggling with one of its most intractable barriers: the slow, variable, and subjective nature of clinical endpoints Traditional assessment scales, ...

Visiogen Inc., an Irvine-based eye device maker, has raised $16.5 million in venture capital financing. The new funding brings Visiogen’s total raised to at least $21.3 million in its two years of ...

June 10 (Reuters) - Skye Bioscience (SKYE.O), opens new tab said on Monday it will discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of a ...

The risk of developing glaucoma can be influenced mostly by an individual's body weight and overall physical health. Read on to know more about this condition. TheHealthSite.com ...

Recent advances in eye tracking have opened new avenues for evaluating cognitive load during software development. By capturing detailed gaze data, researchers can assess how developers process ...

A new study examines the embryogenesis and eye development of the cave-dwelling spider Tegenaria pagana, providing the first detailed description of its developmental stages. By analyzing gene ...